LeserbriefOpen Access · CC BY 4.0
What constitutes disease modification in IgA nephropathy?
Clinical Kidney Journal · 31.07.2026 · 19 (8)
DOI: 10.1093/ckj/sfag265 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Kidney Journal, online erschienen am 10.08.2026. Verfasst von Nobuo Tsuboi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, The Jikei University School of Medicine, Tokyo, Japan. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, The Jikei University School of Medicine, Tokyo, Japan.
- Division of Internal Medicine, Hotta Osamu Clinic, Sendai, Japan.
ORCID-Profile: Nobuo Tsuboi
Zitieren
APA
Tsuboi, N., & Hotta, O. (2026). What constitutes disease modification in IgA nephropathy?. Clinical Kidney Journal, 19(8). https://doi.org/10.1093/ckj/sfag265
Vancouver
Tsuboi N, Hotta O. What constitutes disease modification in IgA nephropathy?. Clinical Kidney Journal. 2026;19(8). doi:10.1093/ckj/sfag265
BibTeX
@article{Tsuboi2026,
author = {Tsuboi, Nobuo and Hotta, Osamu},
title = {What constitutes disease modification in IgA nephropathy?},
journal = {Clinical Kidney Journal},
year = {2026},
volume = {19},
number = {8},
doi = {10.1093/ckj/sfag265}
}
EUVIMED